MarketInOut Stock Screener Log In | Sign Up
 

Lifecore Biomedical Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/25/2026 16:00
Lifecore Biomedical Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization172.23 mln
Float19.33 mln
Earnings Date05/12/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.11
Reliable

1-Year Forecast

6.75
Exceptional upside

Relative Strength

20 / 100
Significantly lagging

Debt / Equity

-4.55
Negative equity

Dividend Yield

0.00%
No dividend

Business Description

Lifecore Biomedical is a contract manufacturer specializing in sterile injectable drugs and medical devices, helping pharmaceutical companies bring their products from early development through to full-scale production. The company is particularly known for its expertise in hyaluronic acid, a material widely used in eye and joint treatments, which it produces in bulk and in ready-to-use syringes and vials. Based in Chaska, Minnesota and founded in 1965, Lifecore serves clients across the United States and Europe, offering a broad range of support services including formulation work, testing, and clinical supply manufacturing.

Key Fundamentals

EPS-1.27
RPS2.36
ROIC-2.56
ROA-13.50
EBITDA, mln-2.44
EV / EBITDA-134
EV / EBIT-35.42
Revenue, mln88.47
EV / Revenue3.70

Financial Strength

Altman Z-Score-0.5
Piotroski F-Score 4 / 9
Beneish M-Score-3.11
1-Year Target Price6.75
Short Ratio15.97
Short % of Float8.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.94% 85 / 100   
1 Month 6.91% 74 / 100   
2 Months 5.94% 67 / 100   
6 Months -35.73% 12 / 100   
1 Year -38.95% 17 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us